BioPharma Credit PLC (BPCR.L) LSE

Currency In USD

AD

Valuation

Market Cap1.04B
Enterprise Value1.03B
P/E Ratio10.35
PEG Ratio-0.77
Price/Sales Ratio9.18
Price/Book Ratio0.98
Enterprise/Revenue8.61
Enterprise/EBITDA18.17

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.89
Operating Margin0.89
AD

Management Effectiveness

Return On Assets0.09
Return On Equity0.09

Income Statement

Revenue140.23M
Revenue/Share0.11
Gross Profit114.5M
EBITDA129.89M
Net Income129.89M
Diluted EPS0.11

Balance Sheet

Total Cash68.71M
Total Cash/Share0.06
Total Debt0
Total Debt/Equity0
Current Ratio26.43
Book Value Per Share1.01

Price History

52-Week Change9.56
52-Week High1
52-Week Low0.88
Moving Average 50 Days0.97
Moving Average 200 Days0.96

Statistics

Average Volume1.61M
Shares Outstanding1.12B
% Held by Institutions0.26

Dividend And Splits

Trailing Annual Dividend Rate0.08
Trailing Annual Dividend Yield8.57
Payout Ratio1.04
Last Split FactorN/A
Last Split DateN/A
AD